XTX Topco Ltd Takes $804,000 Position in Addus HomeCare Corporation (NASDAQ:ADUS)

Key Points

• XTX Topco Ltd has acquired 8,128 shares of Addus HomeCare Corporation, worth approximately $804,000, indicating growing interest from institutional investors.
• Several analysts have upgraded their ratings on Addus HomeCare, with a consensus rating of "Buy" and a price target of $142.57.
• Addus HomeCare reported a 20.3% increase in revenue year-over-year, with a net margin of 6.52% and earnings per share of $1.42 for the last quarter.

XTX Topco Ltd purchased a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 8,128 shares of the company's stock, valued at approximately $804,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Natixis lifted its holdings in shares of Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares during the last quarter. Bailard Inc. bought a new stake in shares of Addus HomeCare in the 1st quarter worth approximately $208,000. Heritage Family Offices LLP boosted its position in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock valued at $239,000 after buying an additional 143 shares during the period. Private Advisor Group LLC boosted its position in Addus HomeCare by 52.4% during the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock valued at $252,000 after buying an additional 875 shares during the period. Finally, Hohimer Wealth Management LLC boosted its position in Addus HomeCare by 6.3% during the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock valued at $253,000 after buying an additional 152 shares during the period. Hedge funds and other institutional investors own 95.35% of the company's stock.

Addus HomeCare Stock Performance

Shares of NASDAQ ADUS traded down $1.63 during trading on Wednesday, reaching $114.94. 254,100 shares of the company traded hands, compared to its average volume of 191,930. The firm has a 50 day simple moving average of $111.82 and a 200-day simple moving average of $108.33. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.20. The stock has a market capitalization of $2.11 billion, a PE ratio of 25.37, a P/E/G ratio of 1.51 and a beta of 0.80. Addus HomeCare Corporation has a 52-week low of $88.96 and a 52-week high of $136.72.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.45 by $0.04. The firm had revenue of $349.44 million for the quarter, compared to the consensus estimate of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.51%. The business's quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.35 EPS. Equities research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. TD Cowen increased their price target on shares of Addus HomeCare from $135.00 to $139.00 and gave the company a "buy" rating in a research report on Wednesday. Macquarie reissued an "outperform" rating and set a $133.00 price target on shares of Addus HomeCare in a research report on Tuesday, June 10th. JMP Securities reissued a "market outperform" rating and set a $150.00 price target on shares of Addus HomeCare in a research report on Wednesday, July 16th. Finally, Wall Street Zen upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Seven equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Buy" and an average target price of $142.86.

Insider Activity

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the firm's stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president owned 7,796 shares of the company's stock, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 4.60% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.